Control of ACAT2 liver expression by HNF1

Camilla Pramfalk, Matthew A. Davis, Mats Eriksson, Lawrence L. Rudel, and Paolo Parini

Medicine Dept., Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm 141 86

Corresponding Author: paolo.parini{at}cnt.ki.se

Acyl-coenzyme A: cholesterol acyltransferase (ACAT) catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty acids. There are two known genes encoding the two ACAT enzymes, ACAT1 and ACAT2 (also known as Soat1 and Soat2). In adult humans, ACAT1 is present in most tissues, whereas ACAT2 is localized to enterocytes and hepatocytes. In this report we aimed to elucidate the mechanisms controlling the liver-specific expression of the human ACAT2 gene. We identified hepatic nuclear factor 1 (HNF1) as an important liver-specific trans-acting element for the human ACAT2 gene using the human hepatocellular carcinoma cell lines HuH7 and HepG2. Targeted deletion of the HNF1 binding site in the DNA sequence abolished not only the basal promoter function in HepG2 and HuH7 cells but also the induction of the ACAT2 promoter by HNF1. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assay demonstrated that the transcription factors, HNF1 $alpha$ and HNF1 $beta$ , interact with this region in the human ACAT2 gene in vitro and in vivo. These data indicate that (a) the identified HNF1 binding site serves as a positive regulator sequence, (b) the binding site is functionally active both in vivo and in vitro, and (c) the transcription factors HNF1 $alpha$ and HNF1 $beta$ , that bind to this site, play an important part in the regulation of the human ACAT2 promoter.

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

A. M. Devlin, R. Singh, T. Bottiglieri, S. M. Innis, and T. J. Green
Hepatic Acyl-Coenzyme A:Cholesterol Acyltransferase-2 Expression Is Decreased in Mice with Hyperhomocysteinemia
J. Nutr., February 1, 2010; 140(2): 231 - 237.
[Abstract] [Full Text] [PDF]

C. Pramfalk, E. Karlsson, L. Groop, L.L. Rudel, B. Angelin, M. Eriksson, and P. Parini
Control of ACAT2 Liver Expression by HNF4{alpha}: Lesson From MODY1 Patients
Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1235 - 1241.
[Abstract] [Full Text] [PDF]

P. Parini, U. Gustafsson, M. A. Davis, L. Larsson, C. Einarsson, M. Wilson, M. Rudling, H. Tomoda, S. Omura, S. Sahlin, et al.
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1200 - 1206.
[Abstract] [Full Text] [PDF]

T. Hiroki, S. A. Liebhaber, and N. E. Cooke
An Intronic Locus Control Region Plays an Essential Role in the Establishment of an Autonomous Hepatic Chromatin Domain for the Human Vitamin D-Binding Protein Gene
Mol. Cell. Biol., November 1, 2007; 27(21): 7365 - 7380.
[Abstract] [Full Text] [PDF]

E. Ikonen
Mechanisms for cellular cholesterol transport: defects and human disease.
Physiol Rev, October 1, 2006; 86(4): 1237 - 1261.
[Abstract] [Full Text] [PDF]